KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Liabilities and Shareholders Equity (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $10.6 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 12.95% to $10.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.0 billion through Dec 2025, up 293.83% year-over-year, with the annual reading at $10.6 billion for FY2025, 12.95% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $10.6 billion at Bio-Rad Laboratories, up from $9.7 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $20.0 billion in Q3 2021, with the low at $1.0 million in Q4 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $9.3 billion, with a median of $10.6 billion recorded in 2025.
  • The sharpest move saw Liabilities and Shareholders Equity surged 44780.0% in 2022, then tumbled 97.44% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $1.0 million in 2021, then soared by 44780.0% to $448.8 million in 2022, then plummeted by 36.03% to $287.1 million in 2023, then soared by 3161.62% to $9.4 billion in 2024, then grew by 12.95% to $10.6 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $10.6 billion, $9.7 billion, and $10.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.